| |
| "...the only people for me are the mad ones, the ones who are mad to live, mad to be saved, desirous of everything at the same time, the ones who never yawn or say a commonplace thing, but burn, burn, burn like the fabulous yellow roman candles exploding like spiders across the stars..."
- Jack Kerouac |
|
|
| Topic: Miscellaneous |
4:22 pm EDT, Apr 17, 2008 |
I am excited that the Preds are doing pretty good in the playoffs!!!! Go Preds!!!! GO PREDATORS!!!!! |
|
|
| Topic: Miscellaneous |
5:09 pm EDT, Apr 14, 2008 |
Learn vocabulary and feed hungry people at the same time. FreeRice |
|
Gotham Prize Honors New Cancer Research - WSJ.com |
|
|
| Topic: Miscellaneous |
7:59 pm EDT, Apr 1, 2008 |
The first annual $1 million Gotham Prize for Cancer Research was awarded to Alexander Varshavsky, a professor of cell biology at the California Institute of Technology. Dr. Varshavsky was honored for a new approach to the treatment of cancer that takes advantage of changes in the DNA of cancer cells. The Gotham Prize was created in 2007 by two hedge-fund managers from private-investment firm Gotham Capital, Robert Goldstein and Joel Greenblatt, as well as Gary Curhan, a professor at Harvard Medical School and associate professor of epidemiology at Harvard School of Public Health.
Cool way to gather ideas - wish I had of heard about this earlier - I would have liked to submit an idea... Gotham Prize Honors New Cancer Research - WSJ.com |
|
US stands to lose a generation of young researchers |
|
|
| Topic: Miscellaneous |
10:43 am EDT, Mar 11, 2008 |
Five consecutive years of flat funding the budget of the National Institutes of Health (NIH) is deterring promising young researchers and threatening the future of Americans’ health, a group of seven preeminent academic research institutions warned today. In a new report released here, the group of concerned institutions (six research universities and a major teaching hospital) described the toll that cumulative stagnant NIH funding is taking on the American medical research enterprise. And the leading institutions warned that if NIH does not get consistent and robust support in the future, the nation will lose a generation of young investigators to other careers and other countries and, with them, a generation of promising research that could cure disease for millions for whom no cure currently exists. US stands to lose a generation of young researchers |
|
|
| Topic: Miscellaneous |
10:54 am EST, Feb 26, 2008 |
to me! |
|
Scientists plot first moves for Project Checkmate |
|
|
| Topic: Miscellaneous |
5:47 pm EST, Feb 25, 2008 |
A collaboration between the Scripps Research Institute and IBM to find new antidotes to flu before new mutations surface is making some initial progress. Dubbed Project Checkmate, scientists are using phage displays to identify antibodies that can be used to fight influenza. The project hopes to employ supercomputers to anticipate the way that the flu mutates and moves. Researchers could develop new drugs for new versions of the flu that had yet to surface in the public. Scientists are waiting to hear back on their grant application to the NIH. This is a very interesting project - if anyone hears anything more about this, please post. Scientists plot first moves for Project Checkmate |
|
New hope for allergy/asthma sufferers |
|
|
| Topic: Miscellaneous |
5:41 pm EST, Feb 25, 2008 |
The research team, funded by the Biotechnology and Biological Sciences Research Council, targeted the p110delta molecule and found that it was possible to interfere in the allergic reaction before symptoms occur, but without shutting down the immune system in mice. It means scientists are a step closer to developing a new class of allergy and asthma drugs. At present treatments focus on alleviating the symptoms. Lead author Dr Khaled Ali said: "p110delta was first identified in 1997 and, although we had our suspicions, at that time we had no idea how important it would turn out to be. This work shows that we have the potential to take control of the body's reaction to an allergen and prevent symptoms from occurring." New hope for allergy/asthma sufferers |
|